DATA OGBANGA: Open Payments
NPI 1841554458 · WILLIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 22 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $50 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $159 |
| Abbott Laboratories | 3 | $81 |
| ABIOMED | 2 | $75 |
| Exact Sciences Corporation | 3 | $56 |
| Novo Nordisk Inc | 2 | $44 |
| Viatris Specialty LLC | 1 | $34 |
| PFIZER INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $16 |
Products named: REPATHA, FREESTYLE LIBRE 3, Rybelsus, YUPELRI, JOT DX, OTEZLA, PREVNAR 20, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
